EPISODE · Jan 31, 2025 · 30 MIN
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 12 Phase-Appropriate Validation vs. Verification
from Cannabinoid and Psychedelic Pharmacology and Drug Development
This podcast episode explores the critical differences between validation and verification in analytical methods, particularly for botanical and fungal products. The discussion covers how validation requirements evolve through different phases of product development, from initial testing to commercial production. Key topics include dealing with natural variability in botanical materials, the importance of robust analytical methods, and how these principles apply to both traditional products and emerging fields like psychedelics. The episode also delves into the challenges of managing mutagenic impurities and implementing appropriate control strategies.
NOW PLAYING
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 12 Phase-Appropriate Validation vs. Verification
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.